Skip to main content
SpringerLink
Log in

Current Safety of the Blood Supply in the United States

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

In common with other developed countries, the United States has placed a great deal of emphasis on blood safety. As a result of careful donor selection and the use of advanced tests, including nucleic acid testing (NAT), the risk of transmission of human immunodeficiency virus and hepatitis C virus has been reduced to about 1 in 1.5 million donations. NAT for hepatitis B virus has not been introduced, but nevertheless the risk is low. Attention recently has been focused on emerging infections. NAT for West Nile virus was implemented within 6 to 8 months of recognition of the need to prevent transfusion transmission of this newly introduced virus. Approximately 1000 potentially infectious donations were identified and removed from the blood supply during the 2003 season. Other emerging infections attracting attention include Chagas’ disease, babesiosis, malaria, and variant Creutzfeldt-Jakob disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42:975–979.

    Article  CAS  Google Scholar 

  2. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004;351:760–768.

    Article  CAS  Google Scholar 

  3. Goodman JL. The safety and availability of blood and tissues: progress and challenges. N Engl J Med. 2004;351:819–822.

    Article  CAS  Google Scholar 

  4. Dodd RY, Leiby DA. Emerging infectious threats to the blood supply. Annu Rev Med. 2004;55:191–207.

    Article  CAS  Google Scholar 

  5. Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. JAMA. 1997;277:967–972.

    Article  CAS  Google Scholar 

  6. Zou S, Dodd RY, Stramer SL, Strong DM. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med. 2004;351:751–759.

    Article  CAS  Google Scholar 

  7. Delwart EL, Kalmin ND, Jones TS, et al. First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang. 2004;86:171–177.

    Article  CAS  Google Scholar 

  8. Phelps R, Robbins K, Liberti T, et al. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion. 2004;44:929–933.

    Article  Google Scholar 

  9. Schüttler CG, Caspari G, Jursch CA, et al. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet. 2000;355:41–42.

    Article  Google Scholar 

  10. Busch MP Closing the windows on viral transmission by blood transfusion. In: Stramer SL, ed. Blood Safety in the New Millenium. Bethesda, MD: American Association of Blood Banks; 2001:33–54.

    Google Scholar 

  11. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42–48.

    Article  CAS  Google Scholar 

  12. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion. 2002;42:1019–1026.

    Article  Google Scholar 

  13. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003;349:1236–1245.

    Article  CAS  Google Scholar 

  14. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med. 2003;349:1205–1206.

    Article  Google Scholar 

  15. Biggerstaff BJ, Petersen LR. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion. 2003;43:1007–1017.

    Article  Google Scholar 

  16. Orton S. Syphilis and blood donors: what we know, what we do not know, and what we need to know. Transfus Med Rev. 2001;15:282–291.

    Article  CAS  Google Scholar 

  17. Orton SL, Liu H, Dodd RY, et al. Prevalence of circulating Treponema pallidum DNA and RNA in blood donors with confirmed- positive syphilis tests. Transfusion. 2002;42:94–99.

    Article  CAS  Google Scholar 

  18. Mungai M, Tegtmeier G, Chamberland M, et al. Transfusion- transmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001;344:1973–1978.

    Article  CAS  Google Scholar 

  19. Leiby DA, Lenes BA, Tibbals MA, et al. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med. 1999;341:1237–1239.

    Article  CAS  Google Scholar 

  20. Leiby DA, Read EJ, Lenes BA, et al. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas’ disease, in US blood donors. J Infect Dis. 1997;176:1047–1052.

    Article  CAS  Google Scholar 

  21. Leiby DA, Rentas FJ, Nelson KE, et al. Evidence of Trypanosoma cruzi infection (Chagas’ disease) among patients undergoing cardiac surgery. Circulation. 2000;102:2978–2982.

    Article  CAS  Google Scholar 

  22. Matsui T, Inoue R, Kajimoto K, et al. First documentation of transfusion-associated babesiosis in Japan [in Japanese]. Rinsho Ketsueki. 2000;41:628–634.

    PubMed  CAS  Google Scholar 

  23. Prusiner SB. Prion diseases and the BSE crisis. Science. 1997;278:245–251.

    Article  CAS  Google Scholar 

  24. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519–550.

    Article  CAS  Google Scholar 

  25. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet. 1999;354:317–323.

    Article  CAS  Google Scholar 

  26. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 2004;364:527–529.

    Article  Google Scholar 

  27. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004;363:417–421.

    Article  CAS  Google Scholar 

  28. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41:1493–1499.

    Article  CAS  Google Scholar 

  29. Ness P, Braine H, King K, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion. 2001;41:857–861.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Blood Services Research and Development, American Red Cross, Jerome H. Holland Laboratory for the Biomedical Sciences, 15601 Crabbs Branch Way, 20855, Rockville, Maryland, USA

    Roger Y. Dodd

Authors
  1. Roger Y. Dodd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roger Y. Dodd.

About this article

Cite this article

Dodd, R.Y. Current Safety of the Blood Supply in the United States. Int J Hematol 80, 301–305 (2004). https://doi.org/10.1532/IJH97.04123

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.04123

Key words

Search

Navigation